Chemical Compound Review:
Betadrenol 1-(2-chloro-5-methyl- phenoxy)-3-(tert...
Synonyms:
Betadran, Panimit, Looser, Bupranolol HCl, dl-KL 255, ...
This record was replaced with 2475.
- Adult hypophosphatasia. Clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Whyte, M.P., Teitelbaum, S.L., Murphy, W.A., Bergfeld, M.A., Avioli, L.V. Medicine (Baltimore) (1979)
- Metabolic bone disease in pseudohypoparathyroidism: radiologic features. Burnstein, M.I., Kottamasu, S.R., Pettifor, J.M., Sochett, E., Ellis, B.I., Frame, B. Radiology. (1985)
- Effects of bupranolol, a new beta-blocker, on platelet functions of rabbit and human in vitro. Umetsu, T., Sanai, K., Kato, T. Thromb. Haemost. (1976)
- Histomorphometric study of ribs with looser zones in Itai-itai disease. Yamashita, H., Kitagawa, M. Calcif. Tissue Int. (1996)
- Osteomalacia in a patient with anorexia nervosa. Verbruggen, L.A., Bruyland, M., Shahabpour, M. J. Rheumatol. (1993)
- Myocardial alpha 1-adrenoceptors mediate positive inotropic effect and changes in phosphatidylinositol metabolism. Species differences in receptor distribution and the intracellular coupling process in mammalian ventricular myocardium. Endoh, M., Hiramoto, T., Ishihata, A., Takanashi, M., Inui, J. Circ. Res. (1991)
- Expression of human (beta)3-adrenergic receptor induces adipocyte-like features in CHO/K1 fibroblasts. Gros, J., Gerhardt, C.C., Strosberg, A.D. J. Cell. Sci. (1999)
- Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes. Doheny, H.C., Lynch, C.M., Smith, T.J., Morrison, J.J. J. Clin. Endocrinol. Metab. (2005)
- beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor. Tavernier, G., Toumaniantz, G., Erfanian, M., Heymann, M.F., Laurent, K., Langin, D., Gauthier, C. Cardiovasc. Res. (2003)
- Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. Tavernier, G., Barbe, P., Galitzky, J., Berlan, M., Caput, D., Lafontan, M., Langin, D. J. Lipid Res. (1996)
- Betablocking drugs in essential hypertension: transdermal bupranolol compared with oral metoprolol. Jeck, T., Edmonds, D., Mengden, T., Schubert, M., Renz, I., Weisser, B., Vetter, W. International journal of clinical pharmacology research. (1992)
- Antihypertensive effects of intra-cisternal beta-blocking agents in dogs with acute nerogenic hypertension. Montastruc, J.L., Montastruc, P. Archives internationales de pharmacodynamie et de thérapie. (1979)
- Atypical cardiostimulant beta-adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues. Malinowska, B., Kieć-Kononowicz, K., Flau, K., Godlewski, G., Kozłowska, H., Kathmann, M., Schlicker, E. Br. J. Pharmacol. (2003)
- Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems. Babu, R.J., Pandit, J.K. International journal of pharmaceutics. (2005)
- Effects of topically applied bupranolol on the intraocular pressure. Effects on the untreated eye. Sakimoto, G., Une, H., Ohba, N. Ophthalmologica (1979)
- The intraocular pressure response of glaucomatous eyes to topically applied bupranolol. A pilot study. Krieglstein, G.K., Sold-Darseff, J., Leydhecker, W. Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology. (1977)
- Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor. Galitzky, J., Langin, D., Verwaerde, P., Montastruc, J.L., Lafontan, M., Berlan, M. Br. J. Pharmacol. (1997)
- A novel analysis of concentration-dependence of partial agonism Ring-demethylation of bupranolol results in a high affinity partial agonist (K 105) for myocardial and tracheal beta-adrenoceptors. Lemoine, H., Kaumann, A.J. Naunyn Schmiedebergs Arch. Pharmacol. (1982)
- Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery. Leblais, V., Pourageaud, F., Ivorra, M.D., Marthan, R., Muller, B. Naunyn Schmiedebergs Arch. Pharmacol. (2005)
- Pronounced direct inhibitory action mediated by adenosine A1 receptor and pertussis toxin-sensitive G protein on the ferret ventricular contraction. Endoh, M., Takanashi, M., Norota, I., Kawabata, Y., Asano, T. Naunyn Schmiedebergs Arch. Pharmacol. (1993)
- Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastric fundus using the beta(3)-adrenoceptor antagonist bupranolol. Horinouchi, T., Koike, K. Pharmacology (1999)
- Nebivolol induces calcium-independent signaling in endothelial cells by a possible beta-adrenergic pathway. Gosgnach, W., Boixel, C., Névo, N., Poiraud, T., Michel, J.B. J. Cardiovasc. Pharmacol. (2001)
- Interactions of bupranolol with the polymorphic debrisoquine/sparteine monooxygenase (CYP2D6). Pressacco, J., Muller, R., Kalow, W. Eur. J. Clin. Pharmacol. (1993)
- Characterization of beta-adrenoceptor subtype in bladder smooth muscle in cynomolgus monkey. Takeda, H., Yamazaki, Y., Akahane, M., Akahane, S., Miyata, H., Igawa, Y., Nishizawa, O. Jpn. J. Pharmacol. (2002)
- Molecular cloning and pharmacological characterization of the bovine beta 3-adrenergic receptor. Piétri-Rouxel, F., Lenzen, G., Kapoor, A., Drumare, M.F., Archimbault, P., Strosberg, A.D., Manning, B.S. Eur. J. Biochem. (1995)
- A sensitive method for determination of cytochrome P4502D6 activity in vitro using bupranolol as substrate. Appanna, G., Tang, B.K., Mller, R., Kalow, W. Drug Metab. Dispos. (1996)
- Effect of bupranolol for BRL37344 and noradrenaline-induced relaxations mediating atypical beta/beta3-adrenoceptor in rat oesophageal muscularis mucosae. Horinouchi, T., Koshikawa, H., Koike, K. Gen. Pharmacol. (1999)
- Determination of carboxybupranolol, the major metabolite of bupranolol, in human plasma by high-performance liquid chromatography. Walmsley, L.M., Brodie, R.R., Chasseaud, L.F. J. Chromatogr. (1984)
- Influence of supersaturation on the pharmacodynamic effect of bupranolol after dermal administration using microemulsions as vehicle. Kemken, J., Ziegler, A., Müller, B.W. Pharm. Res. (1992)
- Transdermal delivery of bupranolol: pharmacodynamics and beta-adrenoceptor occupancy. Wellstein, A., Küppers, H., Pitschner, H.F., Palm, D. Eur. J. Clin. Pharmacol. (1986)
- Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect. Montastruc, J.L., Verwaerde, P., Pelat, M., Galitzky, J., Langin, D., Lafontan, M., Berlan, M. Fundamental & clinical pharmacology. (1999)